AMBER JOHNSON: Open Payments
NPI 1659873644 · KENAI, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 28 payments from 12 companies in 2025. Trend: 2023 $81 · 2024 $147 · 2025 $651
Food & beverage: $574Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $114 |
| ABBVIE INC. | 6 | $103 |
| GENZYME CORPORATION | 3 | $74 |
| Boston Scientific Corporation | 3 | $68 |
| Madrigal Pharmaceuticals | 3 | $63 |
| Lilly USA, LLC | 3 | $57 |
| Ardelyx, Inc. | 2 | $44 |
| QOL Medical, LLC | 1 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: TREMFYA, DUPIXENT, General - Pain Management, REZDIFFRA, OMVOH, IBSRELA, Sucraid, LINZESS.
Industry payments across AK — which companies pay providers there.
